

Benign Prostatic Hyperplasia (BPH) Treatment
Devices Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
The Benign Prostatic Hyperplasia (BPH) Treatment Devices market research reports provide detailed insights on market conditions, trends, and growth opportunities. The market size for BPH treatment devices is projected to reach $2.5 billion by 2025, driven by increasing prevalence of BPH and advancements in minimally invasive treatment options.
Request Sample Report
◍ Endo International (US)
◍ Karl Storz (Germany)
◍ Medtronic (US)
◍ Siemens (Germany)
◍ Lumenis (Israel)
◍ Olympus (Japan)
◍ Urologix (US)
◍ NeoTract (US)
◍ Boston Scientific (US)
◍ Urotech (Germany)
◍ Toshiba (Japan)
◍ Baxter International (US)
The Benign Prostatic Hyperplasia (BPH) Treatment Devices Market is highly competitive with companies like Medtronic, Boston Scientific, and Olympus being key players. These companies offer a range of treatment devices such as laser systems, catheters, and robotic systems to help grow the market. Sales revenue: Medtronic - $1.82 billion, Boston Scientific - $2.71 billion, Olympus - $6.59 billion. Request Sample Report
◍ Hospitals
◍ Ambulatory Surgical Centers
◍ Specialty Clinics
◍ Other
◍ Laser Based Procedure
◍ Other Energy Based Procedure